Use the Search Fields to Find Information
Page 12 of 356
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
ABSTRACT Background A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis-based medicinal products (CBMPs) have shown promise as a
January 11, 2026
UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment
Abstract Introduction Chronic pain (CP) affects 35.0%–51.3% of the UK population, with 67%–88% reporting sleep disturbances. Cannabis-based medicinal products (CBMPs) have shown therapeutic potential in
February 27, 2025
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
Abstract Introduction Palliative care aims to improve quality of life through optimal symptom control and pain management. Cannabis-based medicinal products (CBMPs) have a proven role
March 14, 2024
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis
Please use this link to access this publication. Abstract No analytical assay is currently available for the simultaneous determination of CBD major metabolites in serum or urine
July 24, 2025
U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020
Please use this link to access this publication. Abstract Background: Cannabis policy liberalization has increased cannabis availability for medical or recreational purposes. Up-to-date trends in
February 28, 2024
Two-center experience of cannabidiol use in adults with Dravet syndrome
Abstract We describe real-world experience with cannabidiol (CBD) in adults with Dravet Syndrome (DS) via GW Pharma early access programme at two UK neurology centres.
April 25, 2024
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
BACKGROUND The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for
September 19, 2019
Trends over time in adult cannabis use: A review of recent findings
Please use this link to access this publication. Abstract In the United States, policies regarding the medical and nonmedical use of cannabis are changing rapidly.
May 8, 2025
Trends in youth cannabis use across cannabis legalization: Data from the COMPASS prospective cohort study
Abstract Canada legalized recreational cannabis use for adults on October 17, 2018 with decision-makers emphasising the need to reduce cannabis use among youth. We sought
May 16, 2025
Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022
Please use this link to access this publication. Abstract Background: As medical cannabis availability increases, up-to-date trends in medical cannabis licensure can inform clinical policy
December 2, 2024
Page 12 of 356